An interventional study of Hearing Aid without NR enabled and Hearing Aid with NR(1) in Hearing Loss, sponsored by Sonova AG. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2021-10-05.
Sponsored by Sonova AG · Not applicable, Interventional, and Treatment
Participants will perform two different listening tasks: (1) listening to, and repeating back, sentence lists presented in noise, and (2) Subjective rating of effort \& performance following each condition. During this study, continuous, non-invasive physiological measurements (skin conductance, changes in pupil dilation) will be recorded from participants. Using this paradigm we will be assessing the effect of different hearing aid processing algorithms on listening effort. The study takes the form of a one factor (algorithm), within-subjects design.
Each participant performs the Speech perception task with each algorithm (reference, noise reduction I, noise reduction II, noise reduction III), at two individualized signal-to-noise ratios (SRT90 and SRT50). Additionally subjective performance ratings in real-life will be collected.
1,092 studies on the registry are indexed under Hearing Loss; 235 are open to participants now.
This study's enrollment of 19 is below the median of 40 across 764 interventional studies indexed under Hearing Loss.
Browse Hearing Loss studies →Sonova AG is the lead sponsor of 82 studies on the registry; 6 are open to participants now.
Of its 25 completed or terminated interventional studies of FDA-regulated products, 17 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Hearing Aid without Noise Reduction (NR 0) enabled serves as reference condition.
Device: Hearing Aid without NR enabled
Hearing Aid with Noise Reduction I (NR) enabled.
Device: Hearing Aid with NR(1)
Hearing Aid with Noise Reduction II (NR) enabled.
Device: Hearing Aid with NR(2)
Hearing Aid with Noise Reduction III (NR) enabled.
Device: Hearing Aid with NR(3)
Each participant will be fitted with noise reduction disabled. Disabled means that no sound processing algorithm that removes noise from the speech signal is active.
Each participant will be fitted with the noise reduction program on the same hearing aid. The principle of the noise reduction algorithm is to remove noise from a speech signal with the aim of improving the speech intelligibility and comfort.
Each participant will be fitted with a second noise reduction program on the same hearing aid. The parameterization of this NR algorithm differs from that in NR(1).
Each participant will be fitted with a third noise reduction program on the same hearing aid. The parameterization of this NR algorithm differs from that in NR(1) and NR(2).
Differences in Event-related-skin-conductance
Skin conductance will be recorded from participants during the performance of the auditory task. Analyses will be carried out on the skin conductance response recorded during a time window following each auditory stimulus. It is planned to analyze event-related skin conductance response amplitudes \& latencies (micro-Siemens \& milliseconds).
Time frame: 6 weeks
Differences in Event-related-pupil-dilation (ERPDs)
Pupil dilations will be recorded from the participant during the performance of the auditory tasks. Analyses will be carried out relative to the pre-trial baseline (measured one second prior to the onset of the stimulus), in order to account for differences in baseline physiological activity. It is planned to analyze event-related-pupil-dilations. We use the unit: pixels. The size of a pixel in 1mm\^2 is relative to the distance between the eye and the camera. Even though participants heads were placed on a chin rest that was always the same distance from the camera, the distance between the individual eye and the camera can still be different due to differences in participants' anatomies. Thus, pupil dilation are often reported relative to an individuals' baseline, for example as percent change relative to the baseline. Therefore, we use the unit: pixels, as the use of mm\^2 may be inaccurate.
Time frame: 6 weeks
Oldenburg Sentence Test
Words recalled correctly: words repeated back by participants are logged and the percentage of words recalled correctly calculated.
Time frame: 6 weeks
Sound Quality Ratings
The sound quality ratings will be assessed with the aid of a Multi-Stimulus Test. The data, serving as secondary outcome measure, are collected in the laboratory. The scale ranges from 0 "very bad" to 6 "very good" in increments of 1. Individual sound quality rating from participants are averaged over 3 different acoustic scenes for each hearing aid program.
Time frame: 6 weeks
Spectro-temporal-modulation Detection Thresholds (STM)
Stimuli which contain simultaneous frequency and amplitude modulations of a wide-band noise carrier are presented to the participants. The depth of the modulations is systematically varied and the individual modulation detection thresholds are recorded as a broadband decibel (dB) value. For each participant 4 measures were made and averaged to give a mean STM threshold.
Time frame: 6 weeks
Non-verbal Trail Making Test A & B
The Trail Making Test (TMT) is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible according to a given order. In version A the order is given by increasing digit number (i.e. 1-25) while in version B the order is given by alternating digits and letters (i.e. 1-A-2-B-3-C...). The data, serving as an outcome measure, are time-to-complete the set in seconds.
Time frame: 2 weeks
Digit-Span Test Forward (FW) & Backward (BW)
The digit-span task is used to measure working memory's number storage capacity. Participants will see a sequence of numerical digits and are tasked to recall the sequence correctly, with increasingly longer sequences being tested in each trial. The participant's span is the longest number of sequential digits that can accurately be remembered, which means that the participant recalls two sequences out of a maximum of three sequences correct. Digit-span tasks can be given forwards or backwards, meaning that once the sequence is presented, the participant is asked to either recall the sentence in normal or reverse order.
Time frame: 2 weeks
Go/No-go Task
The Go/No-go task measures inhibitory control. Participants are asked to respond to a Go stimulus as fast as possible but not respond to a No-go stimulus. Go stimuli are presented at a rate much higher than the No-go stimuli to elicit prepotent motor activity. The outcome measure of this task is the number of commission errors (i.e. responding to a No-go stimuli) a participant commits as a measure of their ability to stop prepotent motor activity.
Time frame: 6 weeks
Blood Volume Pulse
Blood volume pulse will be recorded from participants during the performance of the auditory task (non-invasively with a photoplethysmographic (PPG) sensor). Analyses will be carried out on the data recorded during a time window following each auditory stimulus (relative to baseline activity). It is planned to analyze event-related changes in pulse rate and amplitude (beats per minute).
Time frame: 6 weeks
Respiration Data
Respiration rates will be recorded from participants during the auditory task using a belt placed under the ribcage. This data will only be used to control for changes in breathing patterns which may influence skin conductance measurements.
Time frame: 6 weeks
Skin Temperature Data
Skin temperature will be recorded from participants during the auditory task using a small thermometer attached to the outside of the little finger (non-dominant hand). This data will only be used to control for changes in temperature which may influence skin conductance measurements.
Time frame: 6 weeks
Acoustic Reflex Thresholds
Tympanometry will be used to assess the mobility of the eardrum, prior to recording Acoustic Reflex Thresholds (ARTs). Compliance \[ml\], Middle Ear Pressure \[daPa\] and ear canal volume \[ml\] will be recorded and checked that they fall within normal limits. Where this is the case, ARTs will be measured using 0.5, 1 \& 2 kHz stimulus tones ipsi- and contralaterally for each ear. The resulting outcome measure will be the threshold \[dB\] required at each frequency and ear arrangement for a stapedial reflex to be present.
Time frame: 3 weeks
| Milestone | Randomized Condition |
|---|---|
| Started | 19 |
| Completed | 17 |
| Not completed | 2 |
| Withdrew: Withdrawal by subject | 2 |
| Milestone | Randomized Condition |
|---|---|
| Started | 19 |
| Completed | 17 |
| Not completed | 2 |
| Withdrew: Withdrawal by subject | 2 |
| Milestone | Randomized Condition |
|---|---|
| Started | 19 |
| Completed | 17 |
| Not completed | 2 |
| Withdrew: Withdrawal by subject | 2 |
| Milestone | Randomized Condition |
|---|---|
| Started | 19 |
| Completed | 17 |
| Not completed | 2 |
| Withdrew: Withdrawal by subject | 2 |
Skin conductance will be recorded from participants during the performance of the auditory task. Analyses will be carried out on the skin conductance response recorded during a time window following each auditory stimulus. It is planned to analyze event-related skin conductance response amplitudes \& latencies (micro-Siemens \& milliseconds).
| micro Siemens | Hearing Aid Without NR(0) Enabled | Hearing Aid With NR (1) | Hearing Aid With NR(2) | Hearing Aid With NR(3) |
|---|---|---|---|---|
| Differences in Event-related-skin-conductance | 0.221 (0.176 to 0.267) | 0.189 (0.150 to 0.227) | 0.147 (0.099 to 0.195) | 0.126 (0.099 to 0.153) |
Pupil dilations will be recorded from the participant during the performance of the auditory tasks. Analyses will be carried out relative to the pre-trial baseline (measured one second prior to the onset of the stimulus), in order to account for differences in baseline physiological activity. It is planned to analyze event-related-pupil-dilations. We use the unit: pixels. The size of a pixel in 1mm\^2 is relative to the distance between the eye and the camera. Even though participants heads were placed on a chin rest that was always the same distance from the camera, the distance between the individual eye and the camera can still be different due to differences in participants' anatomies. Thus, pupil dilation are often reported relative to an individuals' baseline, for example as percent change relative to the baseline. Therefore, we use the unit: pixels, as the use of mm\^2 may be inaccurate.
| pixels | Hearing Aid Without NR(0) Enabled | Hearing Aid With NR (1) | Hearing Aid With NR(2) | Hearing Aid With NR(3) |
|---|---|---|---|---|
| Differences in Event-related-pupil-dilation (ERPDs) | 217.713 (154.747 to 280.689) | 217.301 (164.876 to 269.726) | 158.732 (113.199 to 204.265) | 186.526 (119.151 to 253.900) |
Words recalled correctly: words repeated back by participants are logged and the percentage of words recalled correctly calculated.
| Percentage of correct words | Hearing Aid Without NR(0) Enabled | Hearing Aid With NR (1) | Hearing Aid With NR(2) | Hearing Aid With NR(3) |
|---|---|---|---|---|
| Oldenburg Sentence Test | 92.778 ± 3.296 | 88.611 ± 6.709 | 96.157 ± 2.271 | 94.398 ± 4.607 |
The sound quality ratings will be assessed with the aid of a Multi-Stimulus Test. The data, serving as secondary outcome measure, are collected in the laboratory. The scale ranges from 0 "very bad" to 6 "very good" in increments of 1. Individual sound quality rating from participants are averaged over 3 different acoustic scenes for each hearing aid program.
| score on a scale | Hearing Aid Without NR(0) Enabled | Hearing Aid With NR (1) | Hearing Aid With NR(2) | Hearing Aid With NR(3) |
|---|---|---|---|---|
| Sound Quality Ratings | 3.275 ± 0.263 | 3.230 ± 0.107 | 3.054 ± 0.208 | 3.157 ± 0.136 |
Stimuli which contain simultaneous frequency and amplitude modulations of a wide-band noise carrier are presented to the participants. The depth of the modulations is systematically varied and the individual modulation detection thresholds are recorded as a broadband decibel (dB) value. For each participant 4 measures were made and averaged to give a mean STM threshold.
| decibel | Study Cohort |
|---|---|
| Spectro-temporal-modulation Detection Thresholds (STM) | -8.181 ± 0.617 |
The Trail Making Test (TMT) is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible according to a given order. In version A the order is given by increasing digit number (i.e. 1-25) while in version B the order is given by alternating digits and letters (i.e. 1-A-2-B-3-C...). The data, serving as an outcome measure, are time-to-complete the set in seconds.
Results for this outcome have not been posted.
The digit-span task is used to measure working memory's number storage capacity. Participants will see a sequence of numerical digits and are tasked to recall the sequence correctly, with increasingly longer sequences being tested in each trial. The participant's span is the longest number of sequential digits that can accurately be remembered, which means that the participant recalls two sequences out of a maximum of three sequences correct. Digit-span tasks can be given forwards or backwards, meaning that once the sequence is presented, the participant is asked to either recall the sentence in normal or reverse order.
Results for this outcome have not been posted.
The Go/No-go task measures inhibitory control. Participants are asked to respond to a Go stimulus as fast as possible but not respond to a No-go stimulus. Go stimuli are presented at a rate much higher than the No-go stimuli to elicit prepotent motor activity. The outcome measure of this task is the number of commission errors (i.e. responding to a No-go stimuli) a participant commits as a measure of their ability to stop prepotent motor activity.
Results for this outcome have not been posted.
Blood volume pulse will be recorded from participants during the performance of the auditory task (non-invasively with a photoplethysmographic (PPG) sensor). Analyses will be carried out on the data recorded during a time window following each auditory stimulus (relative to baseline activity). It is planned to analyze event-related changes in pulse rate and amplitude (beats per minute).
Results for this outcome have not been posted.
Respiration rates will be recorded from participants during the auditory task using a belt placed under the ribcage. This data will only be used to control for changes in breathing patterns which may influence skin conductance measurements.
Results for this outcome have not been posted.
Skin temperature will be recorded from participants during the auditory task using a small thermometer attached to the outside of the little finger (non-dominant hand). This data will only be used to control for changes in temperature which may influence skin conductance measurements.
Results for this outcome have not been posted.
Tympanometry will be used to assess the mobility of the eardrum, prior to recording Acoustic Reflex Thresholds (ARTs). Compliance \[ml\], Middle Ear Pressure \[daPa\] and ear canal volume \[ml\] will be recorded and checked that they fall within normal limits. Where this is the case, ARTs will be measured using 0.5, 1 \& 2 kHz stimulus tones ipsi- and contralaterally for each ear. The resulting outcome measure will be the threshold \[dB\] required at each frequency and ear arrangement for a stapedial reflex to be present.
Results for this outcome have not been posted.
Collected over 7 months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Study Cohort | 0/19 (0%) | 0/19 (0%) | 1/19 (5.3%) |
| Event | Study Cohort |
|---|---|
| Positive test for COVID-19General disorders | 1/19 |
| Age, Continuous(years) | Study Cohort |
|---|---|
| Mean | 74.95 ± 7.42 |
| Sex: Female, Male(Participants) | Study Cohort |
|---|---|
| Female | 4 |
| Male | 15 |
| Race and Ethnicity Not Collected(Participants) | Study Cohort |
|---|
| Region of Enrollment(Participants) | Study Cohort |
|---|---|
| Switzerland | 19 |
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sonova AG